title: Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome.
authors.affiliation: Department of Surgery, University of Pittsburgh School of Medicine, PA 15213.
authors.forename: V P
authors.initials: VP
authors.lastname: Scantlebury
authors.forename: R
authors.initials: R
authors.lastname: Shapiro
authors.forename: J
authors.initials: J
authors.lastname: McCauley
authors.forename: M
authors.initials: M
authors.lastname: Jordan
authors.forename: C
authors.initials: C
authors.lastname: Vivas
authors.forename: W
authors.initials: W
authors.lastname: Irish
authors.forename: A
authors.initials: A
authors.lastname: Tzakis
authors.forename: D
authors.initials: D
authors.lastname: Ellis
authors.forename: N
authors.initials: N
authors.lastname: Gilboa
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006463:Hemolytic-Uremic Syndrome / Q000601:surgery*; D006801:Humans; D007223:Infant; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D016572:Cyclosporine; D016559:Tacrolimus